Quantum Pharma launches new range of products to ease side effects of cancer treatment

Fast-growing service-lead niche pharmaceutical manufacturer, Quantum Pharma plc, which last month reported a 77% rise in half-year pre-tax profits, has launched a new range of in-licensed patented medical devices designed to ease the side effects of cancer treatment. Initially, the range will comprise up to seven products used to lessen the negative impact of chemotherapy and radiotherapy, specifically the inflammation of mucosal membranes of the body.

Chronicle Live